Cargando…
Aging Relevant Metabolite Itaconate Inhibits Inflammatory Bone Loss
Progressive bone loss during aging makes osteoporosis one of the most common and life impacting conditions in geriatric populations. The bone homeostasis is maintained through persistent remodeling mediated by bone-forming osteoblast and bone-resorbing osteoclast. Inflammaging, a condition character...
Autores principales: | Wang, Yuting, Li, Song, Zhao, Liming, Cheng, Peng, Liu, Jian, Guo, Fengjing, Xiao, Jun, Zhu, Wentao, Chen, Anmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353012/ https://www.ncbi.nlm.nih.gov/pubmed/35937818 http://dx.doi.org/10.3389/fendo.2022.885879 |
Ejemplares similares
-
The Role of Osteocytes in Inflammatory Bone Loss
por: Metzger, Corinne E., et al.
Publicado: (2019) -
Metabolite itaconate in host immunoregulation and defense
por: Yang, Wenchang, et al.
Publicado: (2023) -
The Immunomodulatory Metabolite Itaconate Modifies NLRP3 and Inhibits Inflammasome Activation
por: Hooftman, Alexander, et al.
Publicado: (2020) -
Itaconate: A Metabolite Regulates Inflammation Response and Oxidative Stress
por: Li, Ruidong, et al.
Publicado: (2020) -
Gallic acid inhibits osteoclastogenesis and prevents ovariectomy-induced bone loss
por: Zhang, Peng, et al.
Publicado: (2022)